Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non‐small‐cell lung carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|48|1|37-44

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.48, Iss.1, 2018-01, pp. : 37-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation

By  

Oncology, Vol. 87, Iss. 4, 2014-07 ,pp. : 215-223

Karger

Access to resources Recommend Favorite

Survival of Patients with Small Cell Lung Carcinoma in Taiwan

By  

Oncology, Vol. 82, Iss. 1, 2012-01 ,pp. : 19-24

Karger

Access to resources Recommend Favorite

Balance between Cell Division and Cell Death as Predictor of Survival in Patients with Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 76-83

Karger

Access to resources Recommend Favorite

Pretreatment Prognostic Factors for Survival in Non-Small-Cell Lung Cancer: A Multivariate Analysis of 229 Patients

By  

Oncology Research and Treatment, Vol. 21, Iss. 3, 1998-07 ,pp. : 204-210

Karger

Access to resources Recommend Favorite

High‐level expression of Hsp90β is associated with poor survival in resectable non‐small‐cell lung cancer patients

By  

HISTOPATHOLOGY, Vol. 309-0167, Iss. 4, 2015-10 ,pp. : 509-519

John Wiley & Sons Inc

Access to resources Recommend Favorite